FDA drafts new guid­ance on man­u­fac­tur­ing cell and gene ther­a­pies, post­mar­ket tri­al non­com­pli­ance

The FDA on Thurs­day re­leased two new draft guid­ance doc­u­ments re­lat­ed to the man­u­fac­ture of cell and gene ther­a­pies, one di­rect­ing man­u­fac­tur­ers to car­ry out …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER